Bio-Rad Laboratories (BIO-B) Notes Payables (2009 - 2026)
Bio-Rad Laboratories (BIO-B) reported Notes Payables of $400.5 million for Q1 2026, up 33275.0% year-over-year from N/an in Q1 2025, and up 30707.69% quarter-over-quarter from $1.3 million in Q4 2025.
Bio-Rad Laboratories (BIO-B) Notes Payables (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO-B) has 18 years of Notes Payables data on file, last reported at $400.5 million in Q1 2026.
- Notes Payables for Q1 2026 came in at $400.5 million, up 33275.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $400.5 million (up 33275.0% YoY), and the FY2025 annual result was $1.3 million, up 8.33% from the prior year.
- Notes Payables rose to $400.5 million in Q1 2026 per BIO-B's latest filing, from $1.3 million in the prior quarter.
- Over five years, Notes Payables peaked at $400.5 million in Q1 2026 and troughed at $448000.0 in Q3 2022.
- A 5-year average of $24.3 million and a median of $504000.0 in 2022 frame the typical range for Notes Payables.
- The sharpest annual moves came in 2022 and 2026: Notes Payables slumped 74.24% in 2022, then jumped 33275.0% in 2026.
- A 5-year view of Notes Payables shows it stood at $465000.0 in 2022, then rose by 7.53% to $500000.0 in 2023, then soared by 140.0% to $1.2 million in 2024, then advanced by 8.33% to $1.3 million in 2025, then soared by 30707.69% to $400.5 million in 2026.
- Business Quant data shows BIO-B's Notes Payables at $400.5 million in Q1 2026, $1.3 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | - | - | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 400.50 Mn |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 483,000.00 |
| Mar 31, 2024 | 487,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 476,000.00 |
| Jun 30, 2023 | 476,000.00 |
| Mar 31, 2023 | 519,000.00 |
| Dec 31, 2022 | 465,000.00 |
| Sep 30, 2022 | 448,000.00 |
| Jun 30, 2022 | 466,000.00 |
| Mar 31, 2022 | 504,000.00 |
| Dec 31, 2021 | 489,000.00 |
| Sep 30, 2021 | 1.74 Mn |
| Jun 30, 2021 | 1.74 Mn |